EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials

Riccardo Vida, Michele Bartoletti, Marcella Montico, Sandro Pignata, Gustavo Baldassarre, Antonino Ditto, Giulia Zapelloni, Monica Rizzetto, Ludovica Lay, Poletto Margherita, Fabio Puglisi

Cancer Treatment Reviews · 2026-03 · 144 · 103094

DOI: 10.1016/j.ctrv.2026.103094 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cancer Treatment Reviews, 2026-03. Verfasst von Riccardo Vida und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Ital…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Immune Checkpoint Inhibitors, Programmed Cell Death 1 Receptor, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorImmunotherapyB7-H1 AntigenHumansFemaleRandomized Controlled Trials as Topic

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy; Department of Medicine, University of Udine, Udine, Italy.
  • Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy. Electronic address: michele.bartoletti@cro.it.
  • Clinical Trial Office, Scientific Direction, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione G Pascale, Naples, Italy.
  • Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, Aviano, Italy.
  • Gynecologic Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, National Cancer Institute, Aviano, PN, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Vida, R., Bartoletti, M., Montico, M., Pignata, S., Baldassarre, G., Ditto, A., Zapelloni, G., Rizzetto, M., Lay, L., Margherita, P., & Puglisi, F. (2026). Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials. Cancer Treatment Reviews, 144, 103094. https://doi.org/10.1016/j.ctrv.2026.103094

Vancouver

Vida R, Bartoletti M, Montico M, Pignata S, Baldassarre G, Ditto A, et al. Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials. Cancer Treatment Reviews. 2026;144:103094. doi:10.1016/j.ctrv.2026.103094

BibTeX
@article{Vida2026,
  author = {Vida, Riccardo and Bartoletti, Michele and Montico, Marcella and Pignata, Sandro and Baldassarre, Gustavo and Ditto, Antonino and Zapelloni, Giulia and Rizzetto, Monica and Lay, Ludovica and Margherita, Poletto and Puglisi, Fabio},
  title = {Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {144},
  pages = {103094},
  doi = {10.1016/j.ctrv.2026.103094}
}
Kostenlos starten →